Clear Cell Ependymoma Terminated Phase 1 Trials for Vitespen (DB06400)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0086684 (Clear Cell Ependymoma) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02722512 | Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine | Treatment |